vs
Side-by-side financial comparison of CoastalSouth Bancshares, Inc. (COSO) and LENZ Therapeutics, Inc. (LENZ). Click either name above to swap in a different company.
CoastalSouth Bancshares, Inc. is the larger business by last-quarter revenue ($21.3M vs $12.5M, roughly 1.7× LENZ Therapeutics, Inc.). CoastalSouth Bancshares, Inc. runs the higher net margin — 31.7% vs -133.6%, a 165.3% gap on every dollar of revenue. CoastalSouth Bancshares, Inc. produced more free cash flow last quarter ($-5.9M vs $-9.0M).
CoastalSouth Bancshares, Inc. is a U.S.-based regional bank holding company. It provides a full range of personal and commercial banking services including deposit accounts, consumer loans, mortgages, commercial financing and wealth management solutions for retail customers and small-to-medium enterprises across the U.S. Gulf Coast region.
LENZ Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing novel ophthalmic therapies. Its lead product candidates address presbyopia, the age-related loss of near vision, catering to global patient groups with unmet medical needs in the eye care sector.
COSO vs LENZ — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $12.5M |
| Net Profit | $6.7M | $-16.7M |
| Gross Margin | — | — |
| Operating Margin | 41.2% | -151.1% |
| Net Margin | 31.7% | -133.6% |
| Revenue YoY | — | — |
| Net Profit YoY | — | -63.5% |
| EPS (diluted) | $0.54 | $-0.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $21.3M | $12.5M | ||
| Q2 25 | $19.9M | $5.0M | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 |
| Q3 25 | $6.7M | $-16.7M | ||
| Q2 25 | $6.0M | $-14.9M | ||
| Q3 24 | — | $-10.2M | ||
| Q2 24 | — | $-10.3M |
| Q3 25 | 41.2% | -151.1% | ||
| Q2 25 | 35.4% | -337.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | 31.7% | -133.6% | ||
| Q2 25 | 30.0% | -298.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | $0.54 | $-0.59 | ||
| Q2 25 | $0.57 | $-0.53 | ||
| Q3 24 | — | $-0.38 | ||
| Q2 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $25.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $250.4M | $193.9M |
| Total Assets | $2.3B | $210.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $25.4M | ||
| Q2 25 | — | $37.6M | ||
| Q3 24 | — | $41.0M | ||
| Q2 24 | — | $84.0M |
| Q3 25 | $250.4M | $193.9M | ||
| Q2 25 | $209.4M | $206.4M | ||
| Q3 24 | — | $215.3M | ||
| Q2 24 | — | $192.9M |
| Q3 25 | $2.3B | $210.7M | ||
| Q2 25 | $2.2B | $217.3M | ||
| Q3 24 | — | $224.0M | ||
| Q2 24 | — | $202.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-8.6M |
| Free Cash FlowOCF − Capex | $-5.9M | $-9.0M |
| FCF MarginFCF / Revenue | -27.7% | -72.2% |
| Capex IntensityCapex / Revenue | 1.9% | 3.5% |
| Cash ConversionOCF / Net Profit | -0.82× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-47.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-5.5M | $-8.6M | ||
| Q2 25 | $-16.8M | $-11.5M | ||
| Q3 24 | — | $-10.6M | ||
| Q2 24 | — | $-15.8M |
| Q3 25 | $-5.9M | $-9.0M | ||
| Q2 25 | $-17.9M | $-11.7M | ||
| Q3 24 | — | $-10.8M | ||
| Q2 24 | — | $-15.9M |
| Q3 25 | -27.7% | -72.2% | ||
| Q2 25 | -90.3% | -235.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | 1.9% | 3.5% | ||
| Q2 25 | 5.5% | 4.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q3 25 | -0.82× | — | ||
| Q2 25 | -2.82× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
